Memory Formula
Memory Formula, licence 80078872: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Yeepharm Canada Inc.
- NPN or DIN-HM
- 80078872
- Status
- Active licence
- Licence date
- 5 July 2017
- Revision date
- Not provided
- Form
- Capsule, dur
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Ginkgo biloba L.: L'étiquetage des compléments alimentaires qui contiennent la feuille de la plante Ginkgo biloba L. doit comporter un avertissement avec la teneur suivante: "Consultez votre médecin en cas de prise simultanée d'anticoagulants."
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Ginkgo biloba Source : Ginkgo biloba - feuille Extract : Matériel brut sec Extraction ratio : 50.000:1 Dry plant equivalent : 5 Grammes Potency : 24.0 % Flavonoid glycosides | 100.0 milligramme | Not calculated |
| Ginkgo biloba Source : Ginkgo biloba - feuille Potency : 6.0 % Terpene lactones | Not specified | Not calculated |
| Lycium barbarum Source : Lycium barbarum - Fruit Extract : Matériel brut sec Extraction ratio : 10.000:1 Dry plant equivalent : 0.5 Grammes | 50.0 milligramme | Not calculated |
| Panax quinquefolius Source : Panax quinquefolius root Extract : Matériel brut sec Extraction ratio : 5.000:1 Dry plant equivalent : .5 Grammes | 100.0 milligramme | Not calculated |
| Vaccinium angustifolium Source : Vaccinium angustifolium - Fruit Extract : Matériel brut sec Extraction ratio : 36.000:1 Dry plant equivalent : 1.8 Grammes Potency : 40.0 % Anthocyanins | 50.0 milligramme | Not calculated |
| Extrait de pépins de raisin Source : Vitis vinifera - Graine Extract : Matériel brut sec Extraction ratio : 25.000:1 Dry plant equivalent : 2 Grammes Potency : 85.0 % Oligomeric proanthocyanidins | 80.0 milligramme | Not calculated |
Non-medicinal ingredients
Cellulose, Hypromellose, Dextrine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Capsule | 2.0 Jour(s) |
Uses authorised in Canada
(1) Helps to enhance cognitive function in adults. (2) Helps to enhance memory in adults. (3) Helps to support peripheral circulation. (4) Source of antioxidant(s)/Provides antioxidant(s). (5) Traditionally used in Herbal Medicine to help relieve nervousness (as mild sedative). (6) Traditionally used in Herbal Medicine to help relieve nervous dyspepsia / to help digestion in cases of nervousness and/or stress. (7) Used in Herbal Medicine as an adaptogen to help maintain a healthy immune system. (8) Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
(1) Consult a health care practitioner prior to use if you are pregnant or breastfeeding. (2) Consult a health care practitioner prior to use if you are taking medications for diabetes, high blood pressure, or seizures. (3) If you are taking blood thinners, or digoxin, consult a health care practitioner prior to use. (4) If you have diabetes, consult a health care practitioner prior to use.
- Contre-indications
Do not use if you are taking health products that affect blood coagulation (e.g. blood thinners, clotting factor replacements, acetylsalicylic acid, ibuprofen, fish oils, vitamin E) as this may increase the risk of spontaneous bleeding.
Source
Official Health Canada record, licence 80078872
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.